Report #2827886

Received Feb 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: WA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV4	HPV (GARDASIL)	MERCK & CO. INC.	3	—	—
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	3	—	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

3rd HPV vaccine too early; Product origin unknown; This spontaneous report was received from an other health professional and refers to an adult patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated third (3rd) dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) or Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) (reported as HPV vaccine) too early (strength, dose, route of administration, lot # and expiration date were not reported) for prophylaxis (Product origin unknown; Inappropriate schedule of product administration). It was questioned that would they need to repeat it? Lot# is being requested and will submitted if received.